19 related articles for article (PubMed ID: 3077625)
1. Development of four donor-specific phenotypes in human long-term lymphokine-activated killer cell cultures.
Vollenweider I; Moser R; Groscurth P
Cancer Immunol Immunother; 1994 Nov; 39(5):305-12. PubMed ID: 7987862
[TBL] [Abstract][Full Text] [Related]
2. Release of esterase from murine lymphokine-activated killer cells in antibody-dependent cellular cytotoxic reaction.
Kato K; Agatsuma T; Tanabe T; Masuko T; Hashimoto Y
Jpn J Cancer Res; 1991 Feb; 82(2):206-12. PubMed ID: 1900824
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-2-dependent long-term cultures of low-density lymphocytes allow the proliferation of lymphokine-activated killer cells with natural killer, Ti gamma/delta or TNK phenotype.
Testa U; Care A; Montesoro E; Fossati C; Giannella G; Masciulli R; Fagioli M; Bulgarini D; Habetswallner D; Isacchi G
Cancer Immunol Immunother; 1990; 31(1):11-8. PubMed ID: 2306752
[TBL] [Abstract][Full Text] [Related]
4. Regression mechanisms of mouse fibrosarcoma cells after in vitro exposure to quercetin: diminution of tumorigenicity with a corresponding decrease in the production of prostaglandin E2.
Okada F; Hosokawa M; Hasegawa J; Ishikawa M; Chiba I; Nakamura Y; Kobayashi H
Cancer Immunol Immunother; 1990; 31(6):358-64. PubMed ID: 2386981
[TBL] [Abstract][Full Text] [Related]
5. Generation of cell-mediated cytotoxicity against bovine-papilloma-virus-transformed primary mouse cell lines.
Laatikainen A; Karjalainen H; Sarkkinen H; Syrjänen K; Mäntyjärvi R
Cancer Immunol Immunother; 1990; 30(6):351-6. PubMed ID: 2154331
[TBL] [Abstract][Full Text] [Related]
6. Establishment of mouse lymphokine-activated killer cell clones and their properties.
Kato K; Sato N; Tanabe T; Yagita H; Agatsuma T; Hashimoto Y
Jpn J Cancer Res; 1991 Apr; 82(4):456-63. PubMed ID: 1904425
[TBL] [Abstract][Full Text] [Related]
7. Increase in tumor necrosis factor-alpha mRNA but not perforin mRNA expression in response to two newly characterized anti-LFA-1 monoclonal antibodies.
Hommel-Berrey G; Bochan M; Brahmi Z
Nat Immun; 1994; 13(6):301-14. PubMed ID: 7894201
[TBL] [Abstract][Full Text] [Related]
8. Dimethyl 2,2-dichlorovinyl phosphate (DDVP) markedly inhibits activities of natural killer cells, cytotoxic T lymphocytes and lymphokine-activated killer cells via the Fas-ligand/Fas pathway in perforin-knockout (PKO) mice.
Li Q; Nakadai A; Takeda K; Kawada T
Toxicology; 2004 Nov; 204(1):41-50. PubMed ID: 15369847
[TBL] [Abstract][Full Text] [Related]
9. A murine very late activation antigen-like extracellular matrix receptor involved in CD2- and lymphocyte function-associated antigen-1-independent killer-target cell interaction.
Takahashi K; Nakamura T; Koyanagi M; Kato K; Hashimoto Y; Yagita H; Okumura K
J Immunol; 1990 Dec; 145(12):4371-9. PubMed ID: 1979586
[TBL] [Abstract][Full Text] [Related]
10. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
Donskov F; Basse PH; Hokland M
Nat Immun; 1996-1997; 15(2-3):134-46. PubMed ID: 9162263
[TBL] [Abstract][Full Text] [Related]
11. Properties of target molecule of murine lymphokine-activated killer (LAK) cells and the clones.
Hashimoto Y; Kato K; Sato N; Yagi H; Yagita H; Nishimura T
Princess Takamatsu Symp; 1988; 19():315-22. PubMed ID: 3077625
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
